Dan Chen, MD, PhD
Vice President, Clinical Development
Dr. Chen joined OncoC4 with extensive experience in clinical research and drug development. Dr. Chen was a senior director in a number of pharmaceutical and biotech companies, working on development and regulatory approval of new drug products for indications in broad spectrum of therapeutic areas, including oncology, neurology, gastroenterology and pulmonology. Immediately prior to joining OncoC4, Dr. Chen served as medical lead at Jazz Pharmaceuticals where she led multi-function team in design and execution of Phase I to Phase IV studies and the successful submission and approval of two new treatments for patients with sleep disorders. Dr. Chen received her MD from Peking Union Medical College and her PhD in Immunology from Caltech.